FibroBiologics Inc and Charles River Laboratories have announced a letter of intent marking the beginning of a collaboration The agreement paves the way for the transfer testing and validation of FibroBiologics
Flindr Therapeutics BV has recently secured million in Series A financing to advance its innovative pipeline of firstinclass small molecule inhibitors for cancer treatment The financing was led by VBio Ventures
BigHat Biosciences a biotech firm specializing in AIdriven antibody discovery and development has teamed up with Janssen Biotech Inc a Johnson Johnson subsidiary in a strategic collaboration
Multiply Labs and Stanford Medicines Laboratory for Cell Gene Medicine have announced a pioneering collaboration aimed at showcasing the potential of automation technology in cell therapy manufacturing
Xaira Therapeutics launched today with a mission to transform the landscape of medicine discovery and development using cuttingedge AI technologies from start to finish Cofounded by ARCH Venture Partners
Today Benchling announced that Zealand Pharma AS has opted for the Benchling RD Cloud as its central platform for scientific data collaboration and insights Zealand teams will employ the Benchling RD
XOMA Corporation the biotech royalty aggregator announced today it has earned a million milestone related to the US Food and Drug Administrations approval of Day
Compass Therapeutics Inc a clinicalstage oncologyfocused biopharmaceutical company developing proprietary antibodybased therapeutics to treat multiple
Regeneron Pharmaceuticals Inc and Mammoth Biosciences Inc today announced a collaboration to research develop and commercialize in vivo CRISPRbased gene
HOOKIPA Pharma Inc a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform today announced that the Company
Jakarta, Indonesia
Barcelona, Spain
Mumbai, India
Berlin, Germany
London, UK
Boston, MA, USA
Amsterdam, Netherlands
Boston, MA, USA
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Drug safety and pharmacovigilance are critical components of healthcare systems worldwide They play a vital role in monitoring the safety and efficacy of medications ensuring that patients receive treatments
Clinical trials are the backbone of medical research driving innovation and shaping the future of healthcare However the traditional approach to conducting trials often comes with significant environmental costs
Gene therapy has emerged as a promising approach for treating a wide range of genetic disorders and diseases by introducing genetic material into cells to correct or replace abnormal genes In vitro gene therapies conducted in controlled laboratory settings
Hot Melt Extrusion has emerged as a cuttingedge technology in the field of pharmaceutical formulation offering a range of innovative techniques to improve drug delivery and enhance therapeutic outcomes
In the constantly evolving field of drug discovery a new era is on the horizon Artificial Intelligence has emerged as a gamechanger revolutionizing the way drugs are developed AIpowered platforms are dramatically
In the everevolving landscape of drug development advancements in Central Nervous System treatments have taken center stage From mental health disorders to neurodegenerative diseases pharmaceutical companies
Breast cancer is a difficult challenge for the global public health community and the diseases growing prevalence It seems to substantially affect the lives of a large number of females globally by breast cancer
Nectero Medical a leading clinicalstage biotechnology firm dedicated to advancing therapies for aneurysmal diseases has announced that the US Food and Drug Administration
Determining the ability of a target to bind to a drug with high affinity to modulate its function with a therapeutic benefit could be termed Druggability It needs a nontrivial amount of time financial investment
Navigating the complex and dynamic gene therapy regulatory landscape has been a persistent challenge for developers and manufacturers
Antibody drug conjugates ADCs are innovative modalities to deliver chemotherapeutics to specifically targeted populations of cancer cells
Clinical trials form the backbone of pharmaceutical development acting as the proving ground where the safety and efficacy of novel medical interventions are thoroughly evaluated
A number of exciting innovations have begun to gain the attention of companies within the pharmaceutical sector Artificial intelligence AI
The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues
EBR systems are more reliable and compliance than traditional paper documents log in measures